Advancing Research International. LLC (01090)

Clinical research site in Indianapolis, Indiana

As of September 2026, 1 paid clinical trial is recruiting at Advancing Research International. LLC (01090) in Indianapolis, Indiana. Active studies at this site focus on Geographic Atrophy Secondary to Age-related Macular Degeneration alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .

New trial at Advancing Research International. LLC (01090)? We'll email you when one opens.

Recruiting clinical trials at Advancing Research International. LLC (01090) (1)

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for Geographic Atrophy Secondary to Age-related Macular Degeneration
78 locations incl. Gilbert
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All·Age: 60+
Code: NCT07215390·Phase 2·Recruiting·Listed Oct 2025
Apply to this trial

Get new-trial alerts for Advancing Research International. LLC (01090)

We'll email you whenever a new clinical trial starts recruiting at this research site in Indianapolis, IN. Unsubscribe anytime.

More research sites in Indianapolis

Is this your research site?

This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.

Explore more

Paid clinical trials in Indianapolis, IN · Indiana clinical trials